Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in personalized neoantigen vaccines for cancer immunotherapy.

Bioscience trends - 4 Nov 2020

Sun Changbo, Xu Shun

Abstract excerpt

Immunotherapy, which targets T cell inhibitory receptors (immune checkpoints), is now being widely used to treat a variety of types of cancer combined with surgery, chemotherapy, or radiotherapy. However, immune checkpoint inhibitors are highly dependent on the ability to present diverse tumor antigens to T cells. Neoantigens, arising from somatic mutations and specifically targeting tumor cells, have the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Immunogenicity, Vaccine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Precision Medicine

Share to T-Lymphocytes

Share to Tumor Escape

Share to Vaccines, Subunit

Source

Identifiers

PMID: 32908077
DOI: 10.5582/bst.2020.03267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in personalized neoantigen vaccines for cancer immunotherapy.PMID 32908077Read ↗

New emerging targets in cancer immunotherapy: the role of neoantigensSemantic proximity Read ↗

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapySemantic proximity Read ↗

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Semantic proximity Read ↗

Engineering neoantigen vaccines to improve cancer personalized immunotherapySemantic proximity Read ↗

Progress in Neoantigen Targeted Cancer ImmunotherapiesSemantic proximity Read ↗

Characterizing neoantigens for personalized cancer immunotherapy.Semantic proximity Read ↗

Cancer neoantigens as potential targets for immunotherapy.Semantic proximity Read ↗

Cancer Neoantigen Vaccines Emerge Efficacious.Semantic proximity Read ↗

Neoantigens: The Novel Precision Cancer ImmunotherapySemantic proximity Read ↗

The Role of Neoantigens in Cancer ImmunotherapySemantic proximity Read ↗

Identification of neoantigens for individualized therapeutic cancer vaccinesSemantic proximity Read ↗

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.